Vertex (VRTX) Consolidating R&D Ops in Three Locations, Shutters Site in Canada
And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year
Celgene (CELG) Stocks Up on More Juno (JUNO) Stock After Failed Flagship Drug Trial
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
Bay Area's Depomed (DEPO) Craters as New CEO, Directors are Named in Deal With Activist Investor
Vertex (VRTX) Gains Nearly $4 Billion in Market Cap as New Cystic Fibrosis Drug Wows in Two Phase III Studies
Uproar Ensues as Pfizer (PFE) Sends 58 Israeli Doctors to Conference Promoting Its Blood-Thinning Drug Eliquis
AbbVie (ABBV)'s New Approach to Fighting Cancer at Their Roots
Biogen (BIIB) Loses Gene Therapy Pioneer to REGENXBIO
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain
While 3-Way Bids Go On, STADA Arzneimittel (STAGn.DE) CEO's Car is Bugged, Received Photos of Himself in Personal or Private Biz Situations
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor
Never Say Never: Why Taking Out Bristol-Myers Squibb (BMY) Could Boost Pfizer (PFE)'s Value by $5 Billion
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos
3 Best Cancer-Focused Biotechs Investors Should Get In On in 2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's
NYC Data Science Academy Founder Boots Up New Data Scientists’ Careers
Nearly 500 Amgen (AMGN) Staffers to be Reassigned, Relocated or Laid Off in Restructuring
See All News >